| Source Date | Board Meeting Date | Details |
|
21-May-2025
|
26-May-2025
|
Audited Results
|
|
05-Feb-2025
|
13-Feb-2025
|
Quarterly Results
|
|
02-Dec-2024
|
05-Dec-2024
|
Inter alia, to consider and approve the following matters :- 1. The Company is in receipt of In-principle Approval under Regulation 28(1) of the SEBI (Listing Obligations and Disclosure Requirements), Regulations, 2015 vide their letter bearing No. LOD/PREF/TT/FIP/1421/2024-25 dated 2nd December, 2024accorded by Bombay Stock Exchange (BSE); 2. Allotment of 97,28,220 Equity shares at an issue price of Rs. 10/- each aggregating toRs. 9,72,82,200/-; 3. Mr. Hitesh Patel subscribing 57,03,351 Equity shares at an issue price of Rs. 10/- aggregating to Rs. 5,70,33,510/- and this amount will be adjusted against his outstanding loan in the company to the extent of Rs.Rs.5,70,33,510/-; Mr. Hitesh Patel- Promoter of the company also subscribed 11,00,000 convertible warrants into Equity shares; 4. The Company will constitute a shares allotment committee; 5. The Company will preview the progress of acquisition of Himalaya Nutravedics India Private Limited(CIN: U24110TG2022PTC163732) and take necessary steps in this regard; 6. To discuss any other business items with the permission of chair.
|
|
07-Nov-2024
|
13-Nov-2024
|
Quarterly Results
|
|
14-Aug-2024
|
22-Aug-2024
|
Preferential Issue of shares
|
|
09-Aug-2024
|
14-Aug-2024
|
Preferential Issue of shares & Quarterly Results
|
|
05-Jun-2024
|
13-Jun-2024
|
Inter alia, to consider and approve: 1) Appointment of Director; 2) Any other item.
|
|
14-May-2024
|
24-May-2024
|
Audited Results
|
|
29-Jan-2024
|
09-Feb-2024
|
Quarterly Results
|
|
31-Oct-2023
|
09-Nov-2023
|
Quarterly Results
|